arrow
E

Evan S. Dellon

center for esophageal diseases and swallowing
H指数:90
被引数:3.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Diffuse esophageal eosinophilia is associated with increased endoscopic severity and topical steroid non-response in patients with eosinophilic esophagitis

弥漫性食管嗜酸性粒细胞增多与嗜酸性粒细胞性食管炎患者内镜严重程度增加和局部糖皮质激素无应答相关

2026-10-120
PRE
Clinical Trial: Dupilumab Improves Eosinophilic Oesophagitis Outcomes Versus Placebo Regardless of Comorbidities or Treatment History in a Randomised Clinical Trial

临床试验:在随机临床试验中,Dupilumab无论合并症或治疗史如何,均能改善嗜酸性食管炎的结局,且优于安慰剂

2026-10-070
OAAI
The Eosinophilic Esophagitis Severity Index Reflects Response to Budesonide Orodispersible Tablets during Induction and Maintenance Therapy

嗜酸性食管炎严重程度指数反映布地奈德口腔崩解片在诱导和维持治疗期间的反应

2026-08-200
PRE
Baseline characteristics, treatment patterns, and long-term outcomes in patients with eosinophilic esophagitis initiating dupilumab in routine clinical practice: study protocol of a phase IV, prospective, observational, multicenter registry (EDESIA)

基线特征、治疗模式及长期结局:在常规临床实践中起始度普利尤单抗治疗的嗜酸性食管炎患者研究方案——一项IV期、前瞻性、观察性、多中心登记研究(EDESIA)

2026-04-280
PRE
Effect of Budesonide Oral Suspension on Time to First Dysphagia Symptom Response and Dysphagia Symptom Resolution Outcomes in Patients With Eosinophilic Esophagitis

布地奈德口服混悬液对嗜酸性食管炎患者首次吞咽困难症状反应时间和吞咽困难症状缓解结局的影响

2026-02-010
OAAI
Increasing Social Vulnerability Impacts Presentation and Decreases Treatment Response in Eosinophilic Esophagitis

社会脆弱性增加影响嗜酸性粒细胞性食管炎的表现并降低其治疗反应

2025-12-010
OAAI